Table 4. Multivariate HRs for predicting composite study endpoints.
| Variables | HR | 95% CI | p value | ||
|---|---|---|---|---|---|
| Model 1 | |||||
| Age (per 10-year increments) | 2.58 | 1.14–5.55 | 0.023 | ||
| Male | 1.15 | 0.60–2.21 | 0.681 | ||
| Hypertension | 1.16 | 0.60–2.24 | 0.660 | ||
| Diabetes mellitus | 1.29 | 0.56–2.99 | 0.550 | ||
| BMI (per kg/m2) | 1.02 | 0.91–1.13 | 0.755 | ||
| High TACS | 2.09 | 1.01–4.32 | 0.048 | ||
| Model 2 | |||||
| Age (per 10-year increments) | 3.31 | 1.47–7.43 | 0.004 | ||
| Male | 1.64 | 0.81–3.33 | 0.172 | ||
| Hypertension | 1.17 | 0.60–2.26 | 0.651 | ||
| Diabetes mellitus | 1.17 | 0.41–2.68 | 0.720 | ||
| BMI (per kg/m2) | 1.01 | 0.91–1.13 | 0.795 | ||
| LVH | 2.41 | 1.19–4.90 | 0.015 | ||
| Model 3 | |||||
| Age (per 10-year increments) | 2.77 | 1.22–6.28 | 0.015 | ||
| Male | 1.53 | 0.75–3.12 | 0.239 | ||
| Hypertension | 1.90 | 0.99–3.64 | 0.610 | ||
| Diabetes mellitus | 1.27 | 0.95–3.49 | 0.576 | ||
| BMI (per kg/m2) | 1.01 | 0.91–1.12 | 0.843 | ||
| LVH | 2.36 | 1.16–4.78 | 0.015 | ||
| High TACS | 2.03 | 0.98–4.21 | 0.056 | ||
| Model 4 | |||||
| Age (per 10-year increments) | 2.78 | 1.23–6.31 | 0.014 | ||
| Male | 1.52 | 0.82–2.89 | 0.243 | ||
| Hypertension | 1.18 | 0.61–2.29 | 0.620 | ||
| Diabetes mellitus | 1.25 | 0.54–2.89 | 0.601 | ||
| BMI (per kg/m2) | 1.01 | 0.91–1.12 | 0.950 | ||
| LVH + TACS group | |||||
| No LVH + low TACS | - | - | - | ||
| LVH + low TACS | 1.69 | 0.48–5.97 | 0.418 | ||
| No LVH + high TACS | 1.67 | 0.66–42.30 | 0.280 | ||
| LVH + high TACS | 4.51 | 1.71–11.88 | 0.002 | ||
BMI = body mass index; CI = confidence interval; HR = hazard ratio; LVH = left ventricular hypertrophy; TACS = thoracic aorta calcium score.